CAR T-Cell Targeting of Macrophage Colony-Stimulating Factor Receptor
Macrophage colony-stimulating factor receptor (M-CSFR) is found in cells of the mononuclear phagocyte lineage and is aberrantly expressed in a range of tumours, in addition to tumour-associated macrophages. Consequently, a variety of cancer therapies directed against M-CSFR are under development. We...
Main Authors: | Daniela Yordanova Achkova, Richard Esmond Beatson, John Maher |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/14/2190 |
Similar Items
-
T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy
by: Elien De Bousser, et al.
Published: (2021-12-01) -
The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer
by: Giuseppe Schepisi, et al.
Published: (2023-03-01) -
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
by: Piotr Celichowski, et al.
Published: (2023-03-01) -
Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
by: Maria Giraudo, et al.
Published: (2024-03-01) -
Modular Chimeric Antigen Receptor Systems for Universal CAR T Cell Retargeting
by: Ashley R. Sutherland, et al.
Published: (2020-09-01)